Brief: Verve Therapeutics Q3 EPS USD -0.72
07/11/2023 11:38
Nov 7 (Reuters) - Verve Therapeutics Q3 net income USD -45.758 million. * Q3 collaboration revenue USD 3.117 million * Q3 EPS USD -0.72
- $992.16m
- $495.09m
- $32.33m
Nov 7 (Reuters) - Verve Therapeutics Q3 net income USD -45.758 million. * Q3 collaboration revenue USD 3.117 million * Q3 EPS USD -0.72